Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Large-scale discovery of novel genetic causes of developmental disorders

Abstract

Despite three decades of successful, predominantly phenotype-driven discovery of the genetic causes of monogenic disorders1, up to half of children with severe developmental disorders of probable genetic origin remain without a genetic diagnosis. Particularly challenging are those disorders rare enough to have eluded recognition as a discrete clinical entity, those with highly variable clinical manifestations, and those that are difficult to distinguish from other, very similar, disorders. Here we demonstrate the power of using an unbiased genotype-driven approach2 to identify subsets of patients with similar disorders. By studying 1,133 children with severe, undiagnosed developmental disorders, and their parents, using a combination of exome sequencing3,4,5,6,7,8,9,10,11 and array-based detection of chromosomal rearrangements, we discovered 12 novel genes associated with developmental disorders. These newly implicated genes increase by 10% (from 28% to 31%) the proportion of children that could be diagnosed. Clustering of missense mutations in six of these newly implicated genes suggests that normal development is being perturbed by an activating or dominant-negative mechanism. Our findings demonstrate the value of adopting a comprehensive strategy, both genome-wide and nationwide, to elucidate the underlying causes of rare genetic disorders.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Excess of recurrently mutated genes.
Figure 2: Gene-specific significance of enrichment for de novo mutations.
Figure 3: Four novel genes with clustered mutations.
Figure 4: Candidate gene loss-of-function modelling in zebrafish reveals enrichment for developmentally important proteins.

Accession codes

Data deposits

Data can be accessed at the European Genome Phenome Archive (https://www.ebi.ac.uk/ega/) under accession number EGAS00001000775.

References

  1. OMIM. Online Mendelian Inheritance in Manhttp://omim.org (2014)

  2. Cooper, G. M. et al. A copy number variation morbidity map of developmental delay. Nature Genet. 43, 838–846 (2011)

    Article  CAS  Google Scholar 

  3. Allen, A. S. et al. De novo mutations in epileptic encephalopathies. Nature 501, 217–221 (2013)

    Article  ADS  CAS  Google Scholar 

  4. de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921–1929 (2012)

    Article  ADS  CAS  Google Scholar 

  5. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184 (2014)

    Article  ADS  CAS  Google Scholar 

  6. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285–299 (2012)

    Article  CAS  Google Scholar 

  7. Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245 (2012)

    Article  ADS  CAS  Google Scholar 

  8. O'Roak, B. J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246–250 (2012)

    Article  ADS  CAS  Google Scholar 

  9. Rauch, A. et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380, 1674–1682 (2012)

    Article  CAS  Google Scholar 

  10. Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012)

    Article  ADS  CAS  Google Scholar 

  11. Zaidi, S. et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498, 220–223 (2013)

    Article  ADS  CAS  Google Scholar 

  12. King, D. A. et al. A novel method for detecting uniparental disomy from trio genotypes identifies a significant excess in children with developmental disorders. Genome Res. 24, 673–687 (2014)

    Article  CAS  Google Scholar 

  13. Wright, C. F. et al. Genetic diagnosis of developmental disorders in the DDD study: scalable analysis of genome-wide research data. Lancet http://dx.doi.org/10.1016/S0140-6736(14)61705-0 (2014)

  14. Smith, B. H. et al. Cohort profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int. J. Epidemiol. 42, 689–700 (2013)

    Article  Google Scholar 

  15. Samocha, K. E. et al. A framework for the interpretation of de novo mutation in human disease. Nature Genet. 46, 944–950 (2014)

    Article  CAS  Google Scholar 

  16. Boumil, R. M. et al. A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet. 6, e1001046 (2010)

    Article  Google Scholar 

  17. Kumagai, K., Kawano, M., Shinkai-Ouchi, F., Nishijima, M. & Hanada, K. Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT. J. Biol. Chem. 282, 17758–17766 (2007)

    Article  CAS  Google Scholar 

  18. Walter, G. & Ruediger, R. Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways. Cell Cycle 11, 451–459 (2012)

    Article  CAS  Google Scholar 

  19. Lim, E. T. et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77, 235–242 (2013)

    Article  CAS  Google Scholar 

  20. Kettleborough, R. N. et al. A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 496, 494–497 (2013)

    Article  ADS  CAS  Google Scholar 

  21. Pickart, M. A. et al. Genome-wide reverse genetics framework to identify novel functions of the vertebrate secretome. PLoS ONE 1, e104 (2006)

    Article  ADS  Google Scholar 

  22. Craddock, N. & Owen, M. J. The Kraepelinian dichotomy—going, going... but still not gone. Br. J. Psychiatry 196, 92–95 (2010)

    Article  Google Scholar 

  23. Jacquemont, S. et al. A higher mutational burden in females supports a “female protective model” in neurodevelopmental disorders. Am. J. Hum. Genet. 94, 415–425 (2014)

    Article  CAS  Google Scholar 

  24. Levy, D. et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70, 886–897 (2011)

    Article  CAS  Google Scholar 

  25. Goriely, A. & Wilkie, A. O. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am. J. Hum. Genet. 90, 175–200 (2012)

    Article  CAS  Google Scholar 

  26. Huang, N., Lee, I., Marcotte, E. M. & Hurles, M. E. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet. 6, e1001154 (2010)

    Article  Google Scholar 

  27. Helsmoortel, C. et al. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nature Genet. 46, 380–384 (2014)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We dedicate this paper to J. Tolmie and L. Brueton for their unwavering and enthusiastic support of the Deciphering Developmental Disorders project. We thank the families for their participation and patience. We thank M. Daly and K. Samocha for access to unpublished mutation rate estimates. We are grateful to S. Saunders, D. Smedley, D. Conrad, A. Ramu and N. Huang for access to data and algorithms. We thank the UK National Blood Service and the Generation Scotland: Scottish Family Health Study for access to DNA from controls. Generation Scotland has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. The Deciphering Developmental Disorders study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.

Author information

Authors and Affiliations

Consortia

Contributions

See Supplementary Information for author contribution details.

Corresponding author

Correspondence to M. E. Hurles.

Ethics declarations

Competing interests

M.E.H. is a co-founder of, and holds shares in, Congenica Ltd, a genetics diagnostic company.

Extended data figures and tables

Extended Data Figure 1 Characteristics of the families.

a, Gestation-adjusted decimal age (years) at last clinical assessment. The histogram shows the distribution of the gestation-adjusted decimal age at last clinical assessment across the 1,133 probands. The dashed red line shows the median age. b, Frequency of human phenotype ontology (HPO) term usage. Bar plot showing, for each used HPO term, the number of times it was observed across the 1,133 proband patient records. c, Projection PCA plot of the 1,133 probands. PCA plot of 1,133 DDD probands projected onto a PCA analysis using four different HapMap populations from the 1000 genomes project. Black, African; red, European; green, east Asian; blue, south Asian; and the 1,133 DDD probands are represented by orange triangles. d, Self-declared and genetically defined consanguinity. Overlaid histogram showing the distribution of kinship coefficients from KING comparing parental samples for each trio. Green, trios where consanguinity was not entered in the patient record on DECIPHER; red, trios consanguinity was declared in the patient record on DECIPHER.

Extended Data Figure 2 Number of validated de novo SNVs and indels per proband.

Bar plot showing the distribution of the observed number of validated SNVs and indels per proband sample, and the expected distribution assuming a Poisson distribution with the same mean as the observed distribution.

Extended Data Figure 3 Number of diagnoses per gene.

Histogram showing the number of diagnoses per gene for genes with at least two diagnoses from different proband samples.

Extended Data Figure 4 Burden of large CNVs in 1,133 DDD proband samples.

Plot comparing the frequency of rare CNVs in three sample groups against CNV size. The y axis is on a log scale. Red, DDD probands who have not had previous microarray based genetic testing; purple, DDD probands who have had negative previous microarray-based genetic testing; green, DDD controls.

Extended Data Figure 5 Expected and observed numbers of de novo mutations.

The expected and observed numbers of mutations of different functional consequences in three mutually exclusive sets of genes are shown, along with the P value from an assessment of a statistical excess of observed mutations. The three classes of genes are described in the main text.

Extended Data Figure 6 Haploinsufficiency analyses.

a, Saturation analysis for detecting haploinsufficient developmental-disorder-linked genes. A box plot showing the distribution of statistical power to detect a significant enrichment of loss-of-function mutations across 18,272 genes in the genome, for different numbers of trios studied, from 1,000 trios to 12,000 trios. Line within the box shows the median, box shows the interquartile range and the whiskers show the most extreme values within 1.5 times the interquartile range from the box. b, Distribution of haploinsufficiency scores in selected sets of de novo mutations. Violin plot of haploinsufficiency scores in five sets of de novo mutations. Silent, all synonymous mutations; diagnostic, mutations in known developmental-disorder-linked genes in diagnosed individuals; undiagnosed_Func, all functional mutations in undiagnosed individuals; undiagnosed_LoF, all loss-of-function mutations in undiagnosed individuals; undiagnosed_recur, mutations in genes with recurrent functional mutations in undiagnosed individuals. P values for a Mann–Whitney U-test comparing each of the latter four distributions to that observed for the silent (synonymous) variants are plotted at the top of each violin. Dot indicates the median, box is interquartile range and whiskers are the most extreme values within 1.5 times the interquartile range from the box.

Extended Data Table 1 Novel genes with suggestive evidence for a role in developmental disorder
Extended Data Table 2 Biallelic loss of function and damaging functional variants
Extended Data Table 3 Zebrafish modelling identifies 21 developmentally important candidate genes

Supplementary information

Supplementary Information

This file contains detailed methods information for both human genetic analyses and animal modeling experiments, a list of author contributions; full legends for Supplementary Tables 1-8 and a full legend for the Supplementary Data file. (PDF 1179 kb)

Supplementary Information

This zipped file contains Supplementary Tables 1-8 – see the Supplementary Information document for full legends. (ZIP 835 kb)

Supplementary Data

This file contains Zebrafish modeling data - see the Supplementary Information document for a full legend. (PDF 6810 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

The Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 519, 223–228 (2015). https://doi.org/10.1038/nature14135

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature14135

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing